9 completed, 3 recruiting, 3 unknown, 2 withdrawn. 20 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 20 | Completed 9, Recruiting 3, Unknown 3, Withdrawn 2, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1 |
Follow Blood Flow: new trials by email Literature Review of Blood Flow trials Research Report on Blood Flow
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Microvascular Blood Flow During Passive Heating Heat and negative pressure - Blood Flow | Not applicable | Not yet recruiting | San Diego State University | 50 | 2026-08-01 | 2026-03-13 |
| The Relationship Between Blood Flow Readings During Surgery and How Well the Graft Stays Open and How Patients Recover Afterward in Coronary Artery Bypass Graft Surgery Transit-Time Flow Measurement (TTFM) - CABG Graft Integrity, CABG | Not applicable | Recruiting | Weill Medical College of Cornell University | 1242 | 2026-03-30 | 2026-04-22 |
| GastroFlow: Investigation of the Gastrointestinal Blood Flow in Patients With Postprandial Hypotension MRI + GIPR antagonist (Tool), MRI + hangrip, Saline and oral glucose - Postprandial Hypotension, Healthy | Not applicable | Enrolling by invitation | University of Copenhagen | 30 | 2025-09-15 | 2026-02-02 |
| Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Other Perceptual Indicators 400 mg CITRAPEAK® (glucosyl-hesperidin) supplementation, Placebo, 200 mg CITRAPEAK® (glucosyl-hesperidin) supplementation - Exercise Performance, Exercise Recovery | Not applicable | Recruiting | Lindenwood University | 60 | 2025-04-15 | 2025-12-12 |
| The Immediate Effect of Applying Transcutaneous Electrical Nerve Stimulation (TENS) on Sympathetic Ganglion and Gastrocnemius for Popliteal Blood Flow Transcutaneous Electrical Nerve Stimulation，TENS - Transcutaneous Electrical Nerve Stimulation (TENS), Popliteal | Not applicable | Recruiting | Kaohsiung Medical University | 43 | 2024-12-03 | 2025-07-18 |
| Female Pelvic Blood Flow Under Simulated Microgravity Head down tilt (HDT) - Uterine, Ovary | Not applicable | Completed | Ceren UNAL | 20 | 2024-12-01 | 2025-11-28 |
| Understanding Cerebral Blood Flow Dynamics for Alzheimer's Disease Prevention Through Exercise Aerobic exercise condition, Resistance exercise condition - Healthy Aging, Cognitive Function 1, Social | Not applicable | Completed | Universidad de Granada | 20 | 2024-09-25 | 2025-03-25 |
| The Role of GIP in Postprandial Splanchnic Blood Flow Distribution and Metabolism in Patients With Type 2 Diabetes Saline / placebo, GIPR antagonist / study tool - Blood Flow | Not applicable | Completed | University of Copenhagen | 10 | 2023-11-01 | 2026-03-18 |
| Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome Intervention Group, Control Group - Muscle Atrophy, Muscle Weakness | Not applicable | Active not recruiting | Bijan Najafi, PhD | 25 | 2023-08-28 | 2024-12-30 |
| Boosting Performance: The Power of Cranberry Supplementation Cranberry extract - Oxygen Consumption, Mitochondria | Not applicable | Completed | Concordia University, Montreal | 21 | 2023-03-01 | 2024-01-02 |
| Radiofrequency Hyperthermia Safety Study Laser Doppler, Radiofrequency Heating System, Thermal Imaging - Chronic Pain, Soft Tissue Injuries | Not applicable | Completed | Wake Forest University Health Sciences | 20 | 2022-06-27 | 2024-05-03 |
| Regional Blood Flow During Peripheral Heating Peripheral heating of 2 feet, Sham - Blood Flow | Not applicable | Unknown | San Diego State University | 30 | 2022-05-31 | 2024-07-10 |
| The Role of GIP and GLP-2 in Postprandial Splanchnic Blood Flow Distribution and Metabolism GIPR antagonist / study tool, GLP-2R antagonist / study tool, Placebo - Blood Flow | Not applicable | Completed | University of Copenhagen | 10 | 2022-01-13 | 2023-12-26 |
| Effects of Vasopressor on the Graft Blood Flow in TRAM Norepinephrine, Phenylephrine - Blood Flow, Anastomotic Failure of Flap | Not applicable | Completed | Seoul National University Hospital | 20 | 2021-09-24 | 2023-05-03 |
| Effect of AVACEN 100 on Brachial Artery Blood Flow Heat, Vacuum, sham - Blood Flow | Not applicable | Withdrawn | San Diego State University | 2020-02-01 | 2025-05-21 | |
| Efficacy and Safety of Angelica Gigas Nakai and Allium Cepa L.Extract Mixtures on the Improvement of Blood Flow Angelica Gigas Nakai and Allium Cepa L.Extract Mixtures, Placebo - Blood Flow | Not applicable | Unknown | Chonbuk National University Hospital | 80 | 2020-01-30 | 2020-05-15 |
| Efficacy and Safety Morus Alba L. Extract on Improvement of Blood Flow Morus Alba L. Extract, Placebo - Blood Flow | Not applicable | Unknown | Chonbuk National University Hospital | 100 | 2018-11-12 | 2020-05-08 |
| Vasoactive Effects of IQP-AS-118 in Healthy Individuals IQP-AS-118, Placebo - Blood Flow, Cardiovascular Disease | Not applicable | Withdrawn | InQpharm Group | 2018-03-01 | 2020-02-12 | |
| Effect of L-Citrulline on Vascular Function L-citrulline, Placebo - Citrulline, Blood Flow | Not applicable | Completed | Texas Tech University | 25 | 2015-07-01 | 2018-05-04 |
| Vasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Without Type 2 Diabetes Mellitus human glucagon-like peptide 1 (7-36)amide, human glucagon-like peptide 1 (9-36)amide - Type 2 Diabetes, Blod Pressure | Not applicable | Completed | University Hospital, Gentofte, Copenhagen | 20 | 2012-03-01 | 2014-01-31 |
Diabetes Mellitus, Type 2 (2) · Alzheimer Disease (1) · Cardiovascular Diseases (1) · Chronic Pain (1) · Heart Diseases (1) · Motor Activity (1) · Muscle Weakness (1) · Muscular Atrophy (1) · Soft Tissue Injuries (1)
Diabetes Mellitus (2) · Endocrine System Diseases (2) · Glucose Metabolism Disorders (2) · Metabolic Diseases (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Nutritional and Metabolic Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Atrophy (1) · Behavior (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Dementia (1)
Sodium Chloride (2) · Citrulline (1) · Control Groups (1) · Dietary Supplements (1) · Equipment and Supplies (1) · Glucose (1) · Head-Down Tilt (1) · Laser-Doppler Flowmetry (1) · Magnetic Resonance Spectroscopy (1) · Norepinephrine (1) · Phenylephrine (1) · Transcutaneous Electric Nerve Stimulation (1) · Weights and Measures (1) · glucosyl hesperidin (1) · salicylhydroxamic acid (1)
San Diego State University (3) · University of Copenhagen (3) · Chonbuk National University Hospital (2) · Bijan Najafi, PhD (1) · Ceren UNAL (1) · Concordia University, Montreal (1) · InQpharm Group (1) · Kaohsiung Medical University (1) · Lindenwood University (1) · Seoul National University Hospital (1) · Texas Tech University (1) · Universidad de Granada (1) · University Hospital, Gentofte, Copenhagen (1) · Wake Forest University Health Sciences (1) · Weill Medical College of Cornell University (1)
United States (5) · Denmark (4) · South Korea (3) · Canada (1) · Germany (1) · Spain (1) · Taiwan (1) · Turkey (Türkiye) (1)
Afak Durur Karakaya, M.D. (1) · Chad M Kerksick, PhD (1) · Irene Esteban-Cornejo, PhD (1) · Jacob C Sivertsen, MD (1) · Mario Gaudino, MD, PhD, MSCE, FEBCTS, FACC (1) · Nicole Levi, PhD (1) · Ralf Uebelhack (1)